Impact of Antiviral Therapy on Gastroesophageal Varices.
Conditions: Chronic Hepatitis C; CirrhosisInterventions: Drug: Pegylated interferon alfa-2a + Ribavirin; Drug: Pegylated interferon alfa-2a + Ribavirin + Boceprevir; Drug: Pegylated interferon alfa-2a + Ribavirin +Telaprevir; Drug: Ledipasvir/Sofosbuvir; Drug: Ombitasvir/paritaprevir/ritonavir+Dasabuvir; Drug: Daclatasvir+Sofosbuvir; Drug: Simeprevir+SofosbuvirSponsor: Parc de Salut MarActive, not recruiting - verified April 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials